🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical Trial to evaluate the pharmacokinetic Characteristics, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07532148
Aim: To evaluate the effectiveness of a desensitizing gel for topical and h...
Status
Completed
Location
Fabricio Batistin Zanatta
Start Date
2009-11
Trial ID
NCT02128633
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
The aim of this clinical trial is to analyze the negative predictive capaci...
Status
Recruiting
Location
University Hospital Heidelberg, Dermatology
Start Date
2025-01-08
Trial ID
NCT06755281
Treatments Being Tested
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
In metastatic breast cancer (MBC) patients who have already received anthra...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01091168
Treatments Being Tested
This will be a multistate, multicenter clinical study to determine the effi...
Status
Unknown
Location
OMNI Medical Services
Start Date
2018-12-01
Trial ID
NCT03944447
Treatments Being Tested
To evaluate the safety and preliminary efficacy of preoperative chemotherap...
Status
Recruiting
Location
The affiliated hospital of Qingdao university
Start Date
2025-06-01
Trial ID
NCT06647680
Fluorouracil is recommended for the topical treatment of multiple actinic o...
Status
Completed
Location
CBCC Global Research Site 005
Start Date
2022-03-01
Trial ID
NCT05078827